US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about NASDAQ:RNXT

Recent news which mentions NASDAQ:RNXT

RNXT Stock Earnings: RenovoRx Meets EPS for Q2 2024
Tickers RNXT
Tags NASDAQ:RNXT Earnings Reports Market News
From InvestorPlace
RNXT Stock Earnings: RenovoRx Beats EPS for Q1 2024
Tickers RNXT
Tags RNXT Market News NASDAQ:RNXT
From InvestorPlace
RNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023
Tickers RNXT
Tags Earnings Reports NASDAQ:RNXT Market News
From InvestorPlace
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
Tickers IMU RNXT
Tags NASDAQ:RNXT
From News Direct
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
Tickers RNXT
Tags NASDAQ:RNXT
From News Direct
RenovoRx’s Principal Investigator of Phase III Clinical Trial Discusses Positive Interim Results on Patients with Locally Advanced Pancreatic Cancer on OncologyTube
Tags NASDAQ:RNXT
From News Direct
RenovoRX's Latest Innovative Technology Creates New Hope For Chemotherapy Patients
Tags NASDAQ:RNXT
From News Direct